CIM
DGX icon

Caldwell Investment Management’s Quest Diagnostics DGX Stock Holding History

Caldwell Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,800
Closed -$1.61M – 35
2024
Q2 		$1.61M Hold
11,800
– – 1.21% 17
2024
Q1 		$1.57M Hold
11,800
– – 1.17% 22
2023
Q4 		$1.63M Hold
11,800
– – 1.25% 19
2023
Q3 		$1.21M Hold
11,800
– – 1.18% 19
2023
Q2 		$1.64M Hold
11,800
– – 1.24% 17
2023
Q1 		$1.67M Hold
11,800
– – 1.65% 13
2022
Q4 		$1.85M Sell
11,800
-2,300
-16% -$331K 1.95% 11
2022
Q3 		$1.76M Hold
14,100
– – 2.14% 11
2022
Q2 		$1.88M Hold
14,100
– – 1.88% 11
2022
Q1 		$1.96M Hold
14,100
– – 1.55% 11
2021
Q4 		$2.43M Buy
+14,100
New +$2.15M 1.9% 10

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Caldwell Investment Management's DGX Position: Q3 2024 in Review

Caldwell Investment Management sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 11,800 shares — an estimated $1.61M sold.

Caldwell Investment Management first reported a position in DGX in Q4 2021 and held it in 11 quarters. The position peaked at $2.43M in Q4 2021. 846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Caldwell Investment Management reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Caldwell Investment Management sold 11,800 Quest Diagnostics shares in Q3 2024, an estimated $1.61M.
  • Caldwell Investment Management first reported a position in Quest Diagnostics in Q4 2021 and held it in 11 quarters.
  • Caldwell Investment Management's Quest Diagnostics position peaked at $2.43M in Q4 2021.
  • 846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Caldwell Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.